Amorfix Announces Fiscal 2014 First Quarter Results

barbara.lempert TORONTO, Aug. 13, 2013 /CNW/ – Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today ...

Acasti Announces Positive Phase II Open Label Clinical Trial Results

barbara.lempert LAVAL, Quebec, Aug. 13, 2013 (GLOBE NEWSWIRE) — Acasti Pharma (“Acasti” or the “Corporation”) (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies ...

Receptos Announces Issuance of Composition of Matter Patents Covering Proprietary Lead Product Candidate RPC1063

barbara.lempert SAN DIEGO, Aug. 13, 2013 (GLOBE NEWSWIRE) — Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune ...

KaloBios announces retirement of CFO

Alok Saboo FierceBiotech News

Healthcare Businesswomen’s Association Announces its 2013 Leadership Conference, The Art and Science of Leadership

barbara.lempert Boston, MA—August 8, 2013—The Healthcare Businesswoman’s Association (HBA) announced today that it anticipates record-breaking attendance at its 2013 Leadership ...

Sanguine BioSciences Announces Distribution Partnership with AMS Biotechnology

barbara.lempert VALENCIA, Calif., Aug. 8, 2013 – Sanguine BioSciences, a biotechnology company enabling personalized medicine research, today announced a distribution partnership ...

AMRI Announces Second Quarter 2013 Results

barbara.lempert Second Quarter Revenue up 19% at $ 59.3 Million and Adjusted EPS up 100% to $ 0.12 Albany, NY (August 6, 2013) – AMRI (NASDAQ: AMRI) today reported financial and ...

Hyperion Therapeutics Announces Larry J. Singer as Vice President, Manufacturing

barbara.lempert SOUTH SAN FRANCISCO, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) — Hyperion Therapeutics (Nasdaq:HPTX) announced today that Larry J. Singer has joined the company as ...

Athersys Announces Grant to Support Clinical Advancement of Its MultiStem Regenerative Medicine Program

barbara.lempert Athersys Announces Grant to Support Clinical Advancement of Its MultiStem(R) Regenerative Medicine Program for Heart Attack Patients       Athersys Receives SBIR ...

BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia

barbara.lempert – Results published in the British Journal of Hematology – – BL-8040, currently in Phase 2 study for AML, continues to show promising results in ...

ImmunoGen, Inc. Announces FDA Acceptance of IND for Company’s Novel EGFR-Targeting ADC, IMGN289

barbara.lempert •    Novel antibody-drug conjugate (ADC) IMGN289 on track to begin human clinical testing for treatment of EGFR-positive tumors in 4Q2013. •    IMGN289 is ...

QLT Announces Second Quarter 2013 Results

barbara.lempert VANCOUVER, British Columbia, Aug. 1, 2013 (GLOBE NEWSWIRE) — QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) is a biotechnology ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS